Discover why Genmab's antibody platforms, growing royalties, and late-stage pipeline make it a top biotech stock for ...

3SBio will grant Pfizer exclusive global rights, not including China, to develop, manufacture and commercialize SSGJ-707, a ...

Researchers found a significant tradeoff between harms and benefits for patients who received an ICI plus chemotherapy in the first-line setting.

RxDx assay as a companion diagnostic to identify c-Met protein expression in non-squamous NSCLC patients eligible for treatment with Emrelis.

Margrit Wiesendanger, MD, PhD, discusses how lupus treatment is evolving from traditional therapies to more targeted options like biologics, with promising advances now being explored in clinical ...

Lung cancer is the leading cause of cancer-related deaths in the United States, with NSCLC accounting for up to 85% of diagnoses. While surgery has been a primary treatment option for some early ...

Shirley D’Sa discusses how treatment strategies for WM have evolved over the ... So yeah, it's been an interesting evolution throughout my career as a specialist because the disease area took off.

In 2020, Hornady, an ammunition manufacturer, installed a system designed by Powell and Alar Water Treatment. The system uses a rotary vacuum drum systems invented by Alar. “We got it up and ...

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia ...

From trial phases to personalized care, here’s how healthcare providers can navigate cancer clinical trials and guide ...

The European Commission (EC) has granted approval to Bristol Myers Squibb's (BMS) perioperative regimen of neoadjuvant Opdivo ...

This study identifies 53BP1 as an interaction partner of GMCL1 (a likely CUL3 substrate receptor). The study seeks to link this finding to regulation of the mitotic surveillance pathway and paclitaxel ...